Caitong International Asset Management’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
Other funds holding PDSB
MCM
Caitong International Asset Management's PDSB Position: Q2 2026 in Review
Caitong International Asset Management opened a new position in PDS Biotechnology (PDSB) in Q2 2026: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #2906 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in PDSB as recently as Q2 2025.
Caitong International Asset Management first reported a position in PDSB in Q4 2024 and has held it in 4 quarters since. The position peaked at $403 in Q4 2024. 52 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.
- Caitong International Asset Management held 1 share of PDS Biotechnology worth $1 as of Q2 2026.
- PDS Biotechnology was a new Caitong International Asset Management position in Q2 2026.
- PDS Biotechnology made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2906 holding.
- Caitong International Asset Management first reported a position in PDS Biotechnology in Q4 2024 and has held it in 4 quarters since.
- Caitong International Asset Management's PDS Biotechnology position peaked at $403 in Q4 2024.
- 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.
Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.